New developments and therapeutic applications of cardiac stimulating agents.
D002302:Cardiac Output; D002395:Catecholamines / Q000494:pharmacology / Q000627:therapeutic use*; D004071:Digitalis Glycosides / Q000627:therapeutic use* / Q000633:toxicity; D004074:Digitoxin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004077:Digoxin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005934:Glucagon / Q000494:pharmacology / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy; D009638:Norepinephrine / Q000627:therapeutic use
D002395:Catecholamines; D004071:Digitalis Glycosides; D004077:Digoxin; D005934:Glucagon; D004074:Digitoxin; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine